跳至主要内容
临床试验/NL-OMON46844
NL-OMON46844已完成不适用

Role of endothelial surface layer in regulating the sodium balance and extracellular fluid volume - SALT-2 study

Academisch Medisch Centrum0 个研究点目标入组 24 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
已完成
入组人数
24

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • 1. Diabetic patients (n<=12)
  • - Male between 18 and 40 years old
  • - Known with Diabetes Mellitus - type 1
  • - With or without microalbuminuria defined as:
  • o either albuminuria 20-200 mg/L in a morning urine sample
  • o or albuminuria 30-300 mg/24 hrs collected in a 24-hours urine collection
  • o or albumin-to-creatinin ratio 2,5-25 mg/mmol in a morning urine sample.
  • - Stable renal function (creatine clearance > 60 ml/min and < 6 ml/min per year decline) with or without stable therapy with RAAS inhibiting agents
  • - HbA1c levels between 6.0 and 10.0% (42-86 mmol/mol) during the 6 months preceding the study
  • - Multiple injections of insulin a day
  • - Able to provide written informed consent and to comply with the requirements and restrictions listed in the informed consent form;2. HME patients (n<=12)
  • - Male between 18 and 40 years old
  • - Documented Hereditary Multiple Exostoses
  • - Stable renal function (creatinin clearance > 60 ml/min and < 6 ml/min per year decline, no proteinuria)
  • - Able to provide written informed consent and to comply with the requirements and restrictions listed in the informed consent form

排除标准

  • - An office blood pressure >140/90 mmHg
  • - A body mass index > 30 kg/m2
  • - A major illness in the past 3 months or any significant chronic medical illness that the Investigator would deem unfavourable for enrolment, including chronic inflammatory diseases
  • - A history of any type of malignancy within the past 5 years with the exception of successfully treated basal cell cancer of the skin
  • - A history of any renal disease
  • - A history of cardiovascular disease (in the past 6 months) defined as documented coronary artery disease including myocardial infarction, (un-)stable angina pectoris or acute coronary syndrome, precutenaous transluminal coronary angioplasty, coronary artery bypass grafting, cerebrovascular disease including ischemic and hemorrhagic stroke or a subarachnodial bleeding, or peripheral artery disease including aortic aneurysmata
  • - A history of coagulation disorders
  • - A history of primary hyperlipoproteinemias
  • - A history of hypersensitivity or allergy to iodium or to shell fish
  • - A history, within 3 years, of drug abuse (including benzodiazepines, opioids, amphetamine, cocaine, THC, methamphetamine)
  • - A history of alcoholism and/or is drinking more than 3 units of alcohol per day. Alcoholism is defined as an average weekly intake of >21 units for males. One unit is equivalent to 8 g of alcohol: a half-pint (~240 mL) of beer, 1 glass (125 mL) of wine or 1 (25 mL) measure of spirits
  • - Difficulty in donating blood or limited accessibility of a vein in left and right arm
  • - Subject has donated blood in last 3 months
  • - Use of tobacco products
  • - Any other issue that, in the opinion of the Investigator, could be harmful to the subject or compromise interpretation of the data
  • - Any clinically relevant abnormality noted on the 12-lead ECG as judged by the Investigator or an average QTcB or QTcF > 450 millisec

研究者

相似试验